Calico is an independent R&D biotech company established in 2013 by Google Inc. whose goal is to tackle the process of aging. More specifically, Calico’s plan is to use advanced technology to increase understanding of the biology that controls lifespan, and to use that knowledge to increase longevity. The company is led by founder & CEO Arthur D. Levinson, who is the current chairman of Apple Inc. as well as the former chairman of Genentech and was on the board of directors of Hoffmann-La Roche. The name Calico is shorthand for California Life Company. Arthur Levinson had posted he and four others were principal in Calico on Google+. Those four people mentioned were: Robert Cohen, Hal V. Barron, David Botstein and Cynthia Kenyon. Three of the four named are or were previously affiliated with Genentech.
In Google’s 2013 Founders’ Letter, Larry Page described Calico as a company focused on “health, wellbeing and longevity.”
In September 2014, it was announced that Calico, in partnership with AbbVie, would be opening up a R&D facility focused on aging and age-related diseases, such as neurodegeneration and cancer. Initially, each company will invest $250 million, with an option for each to add an extra $500 million later on